The cost of cord blood banking is extremely affordable due to heated competition. Families now have more options to choose from than ever before.
Cord blood banking is becoming an increasingly common practice. More and more, new parents are becoming aware of the benefits of storing their newborn’s umbilical cord blood – a rich source of stem cells that can be used for life-saving medical treatment in the future. However, the biggest barrier for many families, has been the price.
Cord blood banks have been in a stem cell banking price war, and fortunately, it has made storage more affordable.
Why is Cord Blood Banking Necessary
Cord blood is the blood that remains in the umbilical cord connected to the placenta after a child is born. Immediately after birth, this blood is rich in stem cells, which are similar to the stem cells found in an adult’s bone marrow. Cord blood is also rich with red and white blood cells, platelets, and plasma.
The nutrients found in cord blood can be used to treat devastating diseases that can develop later in life, including cancers, metabolic disorders, immune diseases, and blood diseases. Storing your newborn’s cord blood could mean saving their life later down the road.
In the past, cord blood was primarily used in transplants to treat rare diseases. Now, with a rise in clinical trials and technological advancements, stem cells from cord blood and mesenchymal stromal cells (MSCs) from cord tissues are being tested with much broader clinical applications, including the use of T-cells and natural killer (NK) cells for immunotherapies.
This means that the cells found in cord blood and cord tissue can be potentially used in a wider range of treatments, saving even more lives.
Cost Considerations
While cord blood banking has become more popular, it’s always been thought to be very expensive, and therefore a luxury that many families could not sustain. Historically, it would cost up to $2,000 just for the setup and processing fees. It’s important to note that there are two costs to consider with cord blood banking – the initial processing fee, which is paid at the time cord blood is collected, and the storage fee, which is paid annually or prepaid with one-time payment.
As stem cell banking has gained popularity, cord blood banks around the country have begun to compete to get families to store their newborn’s blood at their facilities.
This has led to a significant decrease in the pricing, and more affordable options for families that want them.
Price Competition Benefits Consumers
Private cord blood banks continue to compete aggressively on pricing, financing terms, and bundled services, which has improved affordability for many families. Major U.S. banks such as Cord Blood Registry and ViaCord regularly offer promotional discounts, seasonal campaigns, and extended payment plans that can substantially reduce upfront processing fees. Instead of simple list-price cuts alone, most leading banks now emphasize bundled packages, long-term storage plans, and zero-interest monthly financing to lower the barrier to entry.
Internationally, companies such as HealthBanks continue to promote low monthly payment models for cord blood and cord tissue banking, often pairing these offers with automated processing platforms and high-capacity cryogenic storage systems. HealthBanks’ competitive prices are also paired with a leading automated cell processing system (AXP®) and cutting-edge storage technology, BioArchive®.
Across the industry, marketing has shifted toward total-cost transparency, price guarantees, and flexible installment options rather than one-time headline discounts.
Consolidation and Strategic Acquisitions Continue
Industry consolidation has continued over the past several years, particularly among larger reproductive health and cell therapy service providers. The most notable shift was the acquisition of Cord Blood Registry by CooperSurgical in 2019, placing the world’s largest private cord blood bank inside a broader fertility and women’s health portfolio. CooperSurgical itself operates under The Cooper Companies, reflecting a wider trend of cord blood banking aligning with reproductive medicine and IVF service ecosystems.
Rather than widespread small-bank rollups alone, recent consolidation has focused on strategic integration, linking cord blood banking with fertility clinics, genetic testing services, and reproductive health platforms. Additional mergers, partnerships, and cross-border acquisitions remain likely as scale, regulatory compliance, and long-term storage infrastructure continue to favor well-capitalized operators.
Will the Cost of Cord Blood Banking Continue to Decline?
As cell and gene-based therapy becomes positioned as the next pillar of medicine, more and more consumers will become interested in preserving their stem cells for future use. While the price of cord blood banking is an important factor for attracting new customers, many cord blood banks simply cannot afford to go to a lower price point due to their internal cost structures.
Hence, newborn stem cell banks with automated technology to scale and do processing cost effectively will potentially have a better chance to survive this heated competition and gain market share.
